Organogenesis Is A Prominent Regenerative Medicine Company Based In Cantonmassachusettsfounded In 1985 As A Spin Off From Mitit Focuses On Developingmanufacturingand Commercializing Products For Advanced Wound Caresurgicaland Sports Medicine Marketsthe Company Has Expanded Its Offerings Through Strategic Acquisitionsincluding The Purchase Of Nutech Medical In 2017Which Allowed Entry Into The Surgical And Sports Medicine Sectors The Product Portfolio Includes Apligrafthe First Fda Approved Living Cell Based Product For Treating Venous Leg And Diabetic Foot Ulcersand Dermagraftan Fda Approved Therapy For Diabetic Foot Ulcersother Offerings Include Puraplydesigned For Managing Acute And Chronic Woundsand Additional Products Like Nushieldaffinityfiberospuraforceand Ocmpall Aimed At Enhancing Wound Care And Surgical Applicationsorganogenesis Serves A Wide Range Of Customersincluding Hospitalswound Care Centersand Physician Officeswith A Commitment To Improving Patient Outcomes Through Innovative Solutions
Bio International Convention 2025
United States
16 Jun 2025
435
| Company Name | Organogenesis Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
